# The Misuse of Drugs and Misuse of Drugs (Safe Custody) (Amendment) Regulations (Northern Ireland) 2019, Regulation 2: Amendments to the Misuse of Drugs Regulations (Northern Ireland) 2002


(1) The Misuse of Drugs Regulations (Northern Ireland) 2002 are amended as follows
(2) In paragraph 1(a) of Schedule 3 (controlled drugs subject to the requirements of regulations 14, 15, 16, 18, 22, 23, 24, 26 and 27)—
(a) after “Flunitrazepam” insert—
“Gabapentin (1–(aminomethyl)cyclohexaneacetic acid)”, and
(b) after “Pipradrol” insert—
“Pregabalin ((S)–3–(aminomethyl)-5-methylhexanoic acid)”.
(3) In paragraph 3 of Schedule 3, for “Any ester or ether of pipradrol.” substitute—
“Any—
(a) ester or ether of pipradrol; or
(b) ester of gabapentin (1–(aminomethyl)cyclohexaneacetic acid) or pregabalin ((S)–3–(aminomethyl)-5-methylhexanoic acid)”.

---
Source: https://www.legislation.gov.uk/nisr/2019/21/regulation/2 (the official version)
Page: https://openlegislation.uk/misuse-of-drugs-and-misuse-of-drugs-safe-custody-amendment-regulations-northern-ireland-2019/regulation-2
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

